DrugDashboards

Dobutamine

Dobutamine · DOBUTAMINE HYDROCHLORIDE 12.5 mg/mL · Injection, Solution, Concentrate · Intravenous · HF Acquisition Co LLC, DBA HealthFirst

NDC 51662-1337-03 · 10 POUCH in 1 CASE / 1 VIAL, SINGLE-DOSE in 1 POUCH / 20 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. It is in shortage right now — FDA lists the reason as “other”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Medicare Part B (ASP)

Payment limit per 250 MG
$7.691
HCPCS J1250 · Jul 1, 2026 quarter · typically ASP + 6%

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA074086
TE code
AP
Approval date
Nov 29, 1993
Patents / exclusivity
None on file

Shortage history

  • Planned discontinuation — Dobutamine Hydrochloride, Injection, 12.5 mg/1 mL (NDC 0409-2344-88)Aug 27, 2025
  • In shortage now — Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-01)Nov 6, 2017
    month 106 — 5× the typical 20-month injectable shortage
  • In shortage now — Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-02)Nov 6, 2017
    month 106 — 5× the typical 20-month injectable shortage
  • In shortage now — Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-88)Nov 6, 2017
    Other
    month 106 — 5× the typical 20-month injectable shortage

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Dobutamine (Injection, Solution, Concentrate)

LabelerStrengthFirst seenLast seen
Hospira, Inc.DOBUTAMINE HYDROCHLORIDE 12.5 mg/mLJul 15, 2026Sep 3, 2026
HF Acquisition Co LLC, DBA HealthFirstDOBUTAMINE HYDROCHLORIDE 12.5 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Dobutamine — NDC 51662-1337-03," retrieved September 3, 2026, https://drugdashboards.com/drug/51662133703.

Free to cite with attribution — see how the data is put together.